Professional Documents
Culture Documents
Acknowledgments
Janice Ritchie Saia, RN, EMT-P, of St. Petersburg, FL, first developed these materials. She has generously donated her work to the AHA. Steve Anderson, MD, of Auburn, WA, provided helpful scripts for this case. Mary Fran Hazinski, RN, MSN, and John Field, MD, provided many refinements during final review. We appreciate the hard work of each of these people.
Learning Objectives
After completing this learning station you should be able to Apply the Five Quadrads Approach to patients with complex cardiovascular emergencies Discuss, assess, and manage acute MI Identify ECG changes consistent with Myocardial ischemia/infarction Location of infarct Infarct-related coronary artery
3
Case History
Mr. B. Skimmer, age 45, complains of chest discomfort, nausea, severe fatigue Past Med Hx: hypertension (poor control), 2 to 3 pack/day cigarettes, high stress job Refuses coworkers assistance States: Its just the flu Goes to break room to rest
4
Case Progression
One hour later a coworker finds Mr. Skimmer lethargic, pale, profusely diaphoretic Coworker offers to drive Mr. Skimmer to ED, only 3 minutes away Should Mr. Skimmer go to ED by ALS ambulance? WHY?
5
Case Progression
Mr. Skimmer arrives at your ED with O2 via NRB; IV LR @ KVO Received MONA in field; BP dropped alarmingly, near syncope Triaged as urgent Placed in ED critical care bed
What should you as the key ACLS provider do first?
6
Assessment
Five Quadrads Approach
Primary Survey Airway: adequate Breathing: present with equal chest rise, adequate tidal volume Circulation: pulse present carotid and radial Defibrillation: not needed
8
Assessment
Five Quadrads Approach
Secondary Survey
Airway: adequate Breathing: lung sounds clear Oxygen sat 97% with NRB Circulation: sinus rhythm 2-mm ST-elevation in leads II, III, aVF BP 126/84 mm Hg; IV access present Differential diagnosis: AMI. Others?
9
Assessment
Five Quadrads Approach
OxygenIVmonitorfluids Started by EMS; continued in ED Vital signs T=99.1F, BP=126/84 mm Hg, HR=74 bpm, RR=28/min Tanktankpumprate Consider sources of hemodynamic compromise
10
11
Immediate ED Assessments
O2IVmonitorfluids (done by EMS) Grade chest pain: character, intensity H & P: focus on thrombolytic screening VS frequent recordings Multilead ECG? (12, 15, or 22 leads) First set serum markers Electrolytes; coagulation studies Portable chest film
12
13
I lateral
aVR
V1 septal
V4 anterior
II inferior
aVL lateral
V2 septal
V3 anterior
V5 lateral
V6 lateral
III inferior
aVF inferior
14
ECG 1: Interpretation?
15
ECG 1: elevated ST segments; inferior leads (II, III, aVF); ST depression: precordial leads V2-V5; lateral leads I, aVL Suspect occlusion right coronary artery
16
Right
Septal wall of LV Anterior and lateral walls of LV Inferior wall LV (10%) Both bundle branches
17
Circumflex artery Left anterior descending artery Lateral wall I, aVL, V5-V6
18
NOTE 3: KEY you must obtain a RIGHTRight coronary SIDED ECG at once.
artery
V1
V2
V3R
V6R V5R V4R
20
Inferior lead changes RV infarction? Use lead V4R (ST elevation >1 mm) Clinical significance: Increased mortality Preload dependence Vasodilators may cause severe hypotension What is management of RV infarction?
21
22
23
Nitroglycerin
24
Narcotic Analgesia
Morphine sulfate readily available Effects Relieves pain and anxiety Reduces myocardial oxygen needs Administration 2 to 5 mg IV q 5 minutes (slow) Caution N & V, low BP, respiratory depression
25
Aspirin
Aspirin inhibits platelet cyclo-oxygenase decreases thromboxane A2 production Aspirin benefits Reduces overall mortality in AMI Reduces incidence of nonfatal reinfarction Dose: 160 to 325 mg PO ASAP
26
-Blockers
Mechanism of action Block catecholamines from binding to -adrenergic receptors Nonselective and cardioselective Reduce HR, BP, myocardial contractility, and oxygen consumption Decrease AV nodal conduction
27
-Blockers
Absolute Cautions contraindications Mild/moderate CHF Severe CHF/PE Bradycardia Hypotension (HR <60 bpm) (SBP <100 mm Hg) Hx asthma Bronchospasm IDDM 2nd- or 3rd-degree Severe peripheral AV block vascular disease
28
Heparin
Mechanism of action Indirect thrombin inhibitor (with AT III) Indications PTCA or CABG With fibrin-specific lytics (eg, alteplase) High risk for systemic emboli Large anterior MI, atrial fib, LV thrombus
29
ACE Inhibitors
Mechanism of action Lower BP by inhibiting angiotensinconverting enzyme (ACE) Attenuate LV remodeling by inhibiting tissue ACE Lower peripheral vascular resistance by vasodilatation mechanism Reduce mortality from AMI
30
Potassium deficiency but not magnesium deficiency associated with arrhythmias, sudden death Recent studies suggest no reduction in AMI mortality with magnesium administration
31
Case Progression
32
Relative contraindications
Previous hemorrhagic stroke any time Other stroke, CVA within 1 year; IC neoplasm Active internal bleeding (not menses) Suspected aortic dissection
Severe uncontrolled hypertension (>180/110) Current use of anticoagulants Recent trauma (2 to 4 wk); major surgery <3 wk Recent internal bleeding, active peptic ulcer Pregnancy Streptokinase allergy
33
Direct treatment Mechanical reperfusion of infarct-related coronary artery Best outcome achieved for patients with AMI plus cardiogenic shock
34
Case Progression
Mr. Skimmer received oxygen, aspirin, metoprolol IV, and heparin No nitroglycerin or morphine in ED Now pain-free; stable BP; O2 sat 98% Reperfusion therapy: t-PA + heparin
35
ECG 2: Interpretation?
36
Case Progression
Mr. Skimmer transferred to CCU Uneventful night No chest pain or shortness of breath No arrhythmias Treatment: Oxygen at 2 L/min Heparin, ACE inhibitors, -blockers Nitroglycerin not given
37
38
Primary Survey: no CPR or defibrillation indicated Secondary Survey Airway: adequate Breathing: dyspnea, + JVD, rales in lower third of lung fields Circulation: diaphoretic; peripheral pulses weak Differential diagnosis: obtain 12-lead ECG
39
OxygenIVmonitorfluids Vital signs BP 76/64 mm Hg, HR 80 bpm, RR 32/min Tanktankpumprate What is the nature of the problem? Check 12-lead ECG
40
ECG 3: Interpretation?
SR with ST-segment elevation in leads II, III, aVF; reciprocal changes throughout
41
Treatment Considerations
Acute Pulmonary Edema With Hypotension
First-line Actions
Second-line Actions
Dopamine
42
Treatment Considerations
Priority actions Thrombolytic therapy (repeat t-PA) Coronary angiography and angioplasty or emergency surgical revascularization Intra-aortic balloon pump
43
Differential Diagnosis
Reocclusion RCA; infarct extension Mechanical complications (eg, mitral regurgitation, VSD) Low cardiac output Pulmonary embolus
44
Case Progression
Pulmonary edema persists Cardiogenic shock continues Patient remains hypotensive ECG: ST elevation consistent with reocclusion Strategy: coronary angiography Outcome: angioplasty and stent proximal RCA
45
Summary
Five Quadrads
Layered approach; guides actions and thinking Apply whenever you arrive at an emergency setting
Summary
A focused history and assessment facilitates early initiation of reperfusion therapy The 12-lead ECG may be used to localize injury and guide therapy Serum markers may be used to triage patients and assess prognosis
47
Summary
Several treatments help patients by Decreasing mortality Limiting extent of infarction Limiting incidence of reinfarction Knowledge of complicated AMIs enables us to Anticipate complications Care for patients with complex acute coronary syndromes
48